Try it
Biochemistry · Folate metabolism
Sample itemWhich medication inhibits dihydrofolate reductase in human cells and can cause megaloblastic changes?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Methotrexate
Methotrexate inhibits human dihydrofolate reductase, reducing tetrahydrofolate availability for purine and thymidylate synthesis. Folinic acid can rescue normal cells in selected protocols.
Option by option
A. Acyclovir
Acyclovir inhibits viral DNA polymerase after activation.
B. Allopurinol
Allopurinol inhibits xanthine oxidase.
C. Atorvastatin
Atorvastatin inhibits HMG-CoA reductase.
D. Methotrexate (correct)
Correct. DHFR inhibition is methotrexate's key biochemical action.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…